Selected article for: "basis provide and double strand"

Author: Kumari, Smita; Sharma, Sudhanshu; Advani, Dia; Khosla, Akanksha; Kumar, Pravir; Ambasta, Rashmi K.
Title: Unboxing the molecular modalities of mutagens in cancer
  • Cord-id: x8p7rmtc
  • Document date: 2021_10_5
  • ID: x8p7rmtc
    Snippet: The etiology of the majority of human cancers is associated with a myriad of environmental causes, including physical, chemical, and biological factors. DNA damage induced by such mutagens is the initial step in the process of carcinogenesis resulting in the accumulation of mutations. Mutational events are considered the major triggers for introducing genetic and epigenetic insults such as DNA crosslinks, single- and double-strand DNA breaks, formation of DNA adducts, mismatched bases, modificat
    Document: The etiology of the majority of human cancers is associated with a myriad of environmental causes, including physical, chemical, and biological factors. DNA damage induced by such mutagens is the initial step in the process of carcinogenesis resulting in the accumulation of mutations. Mutational events are considered the major triggers for introducing genetic and epigenetic insults such as DNA crosslinks, single- and double-strand DNA breaks, formation of DNA adducts, mismatched bases, modification in histones, DNA methylation, and microRNA alterations. However, DNA repair mechanisms are devoted to protect the DNA to ensure genetic stability, any aberrations in these calibrated mechanisms provoke cancer occurrence. Comprehensive knowledge of the type of mutagens and carcinogens and the influence of these agents in DNA damage and cancer induction is crucial to develop rational anticancer strategies. This review delineated the molecular mechanism of DNA damage and the repair pathways to provide a deep understanding of the molecular basis of mutagenicity and carcinogenicity. A relationship between DNA adduct formation and cancer incidence has also been summarized. The mechanistic basis of inflammatory response and oxidative damage triggered by mutagens in tumorigenesis has also been highlighted. We elucidated the interesting interplay between DNA damage response and immune system mechanisms. We addressed the current understanding of DNA repair targeted therapies and DNA damaging chemotherapeutic agents for cancer treatment and discussed how antiviral agents, anti-inflammatory drugs, and immunotherapeutic agents combined with traditional approaches lay the foundations for future cancer therapies. [Image: see text]

    Search related documents:
    Co phrase search for related documents
    • action mechanism and acute myeloid leukemia: 1, 2, 3, 4, 5
    • action mechanism and additional focus: 1
    • action mechanism and adjuvant therapy: 1, 2, 3, 4
    • action mechanism and adp ribose: 1, 2
    • action mechanism and adp ribose polymerase: 1
    • action mechanism and adp ribosylation: 1
    • action mechanism and liver cancer: 1
    • action mechanism and long history: 1, 2, 3, 4, 5
    • action mechanism and long short: 1
    • action mechanism and long term safety: 1, 2, 3, 4, 5, 6, 7
    • action mechanism and long term survival: 1
    • action mechanism and low oxygen: 1, 2
    • action mechanism and lox lipoxygenase: 1
    • action mechanism and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • action mechanism and lung cancer cell: 1, 2, 3, 4, 5
    • action mechanism and lymphoma cell: 1, 2
    • action mechanism and m1 macrophage: 1, 2
    • action mechanism and macrophage neutrophil: 1
    • action mechanism and magnesium zinc: 1